Active Ingredient: COPANLISIB DIHYDROCHLORIDE
Proprietary Name: ALIQOPA
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 60MG/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209936
Product Number: 001
Approval Date: Sep 14, 2017
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information